187 related articles for article (PubMed ID: 19876913)
21. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
22. AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.
Brolih S; Parks SK; Vial V; Durivault J; Mostosi L; Pouysségur J; Pagès G; Picco V
BMC Cancer; 2018 Mar; 18(1):249. PubMed ID: 29506489
[TBL] [Abstract][Full Text] [Related]
23. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity.
Frech M; Andjelkovic M; Ingley E; Reddy KK; Falck JR; Hemmings BA
J Biol Chem; 1997 Mar; 272(13):8474-81. PubMed ID: 9079675
[TBL] [Abstract][Full Text] [Related]
24. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
Franke TF; Yang SI; Chan TO; Datta K; Kazlauskas A; Morrison DK; Kaplan DR; Tsichlis PN
Cell; 1995 Jun; 81(5):727-36. PubMed ID: 7774014
[TBL] [Abstract][Full Text] [Related]
25. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.
Rigby S; Huang Y; Streubel B; Chott A; Du MQ; Turner SD; Bacon CM
J Biol Chem; 2009 Sep; 284(39):26871-81. PubMed ID: 19535334
[TBL] [Abstract][Full Text] [Related]
26. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain.
Klippel A; Kavanaugh WM; Pot D; Williams LT
Mol Cell Biol; 1997 Jan; 17(1):338-44. PubMed ID: 8972214
[TBL] [Abstract][Full Text] [Related]
27. Ceramide dissociates 3'-phosphoinositide production from pleckstrin homology domain translocation.
Stratford S; DeWald DB; Summers SA
Biochem J; 2001 Mar; 354(Pt 2):359-68. PubMed ID: 11171115
[TBL] [Abstract][Full Text] [Related]
28. Specific binding of the C-terminal Src homology 2 domain of the p85alpha subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate. Localization and engineering of the phosphoinositide-binding motif.
Ching TT; Lin HP; Yang CC; Oliveira M; Lu PJ; Chen CS
J Biol Chem; 2001 Nov; 276(47):43932-8. PubMed ID: 11555646
[TBL] [Abstract][Full Text] [Related]
29. Epistatic and functional interactions of catechol-o-methyltransferase (COMT) and AKT1 on neuregulin1-ErbB signaling in cell models.
Sei Y; Li Z; Song J; Ren-Patterson R; Tunbridge EM; Iizuka Y; Inoue M; Alfonso BT; Beltaifa S; Nakai Y; Kolachana BS; Chen J; Weinberger DR
PLoS One; 2010 May; 5(5):e10789. PubMed ID: 20520724
[TBL] [Abstract][Full Text] [Related]
30. Phospholipase C regulation of phosphatidylinositol 3,4,5-trisphosphate-mediated chemotaxis.
Kortholt A; King JS; Keizer-Gunnink I; Harwood AJ; Van Haastert PJ
Mol Biol Cell; 2007 Dec; 18(12):4772-9. PubMed ID: 17898079
[TBL] [Abstract][Full Text] [Related]
31. Structure of autoinhibited Akt1 reveals mechanism of PIP
Truebestein L; Hornegger H; Anrather D; Hartl M; Fleming KD; Stariha JTB; Pardon E; Steyaert J; Burke JE; Leonard TA
Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385319
[TBL] [Abstract][Full Text] [Related]
32. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism.
Powell DJ; Hajduch E; Kular G; Hundal HS
Mol Cell Biol; 2003 Nov; 23(21):7794-808. PubMed ID: 14560023
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5.
Hidaka K; Kanematsu T; Takeuchi H; Nakata M; Kikkawa U; Hirata M
Int J Biochem Cell Biol; 2001 Nov; 33(11):1094-103. PubMed ID: 11551825
[TBL] [Abstract][Full Text] [Related]
34. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
35. The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy.
Sundaresan NR; Pillai VB; Wolfgeher D; Samant S; Vasudevan P; Parekh V; Raghuraman H; Cunningham JM; Gupta M; Gupta MP
Sci Signal; 2011 Jul; 4(182):ra46. PubMed ID: 21775285
[TBL] [Abstract][Full Text] [Related]
36. Direct evidence for the action of phosphatidylinositol (3,4,5)-trisphosphate-mediated signal transduction in the 2-cell mouse embryo.
Li Y; Chandrakanthan V; Day ML; O'Neill C
Biol Reprod; 2007 Nov; 77(5):813-21. PubMed ID: 17634444
[TBL] [Abstract][Full Text] [Related]
37. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of AKT: a mutational analysis.
Hart JR; Vogt PK
Oncotarget; 2011 Jun; 2(6):467-76. PubMed ID: 21670491
[TBL] [Abstract][Full Text] [Related]
39. BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse models.
Politz O; Siegel F; Bärfacker L; Bömer U; Hägebarth A; Scott WJ; Michels M; Ince S; Neuhaus R; Meyer K; Fernández-Montalván AE; Liu N; von Nussbaum F; Mumberg D; Ziegelbauer K
Int J Cancer; 2017 Jan; 140(2):449-459. PubMed ID: 27699769
[TBL] [Abstract][Full Text] [Related]
40. A unique platform for H-Ras signaling involving clathrin-independent endocytosis.
Porat-Shliom N; Kloog Y; Donaldson JG
Mol Biol Cell; 2008 Mar; 19(3):765-75. PubMed ID: 18094044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
